DOUBLE DIPPER: COMORBID DEPRESSION AND DIABETES, FROM A BIOMARKER TO TREATMENT. SHOULD ENDOCRINOLOGISTS BE EDUCATED TO BE AT THE FOREFRONT OF DEPRESSION TREATMENT?

被引：0
|
作者：
Barengolts, Elena [1 ,2 ]
机构：
[1] Univ Illinois, 835 South Wolcott St,6th Floor,E625, Chicago, IL 60612 USA
[2] Jesse Brown VAMC, 835 South Wolcott St,6th Floor,E625, Chicago, IL 60612 USA
来源：
ENDOCRINE PRACTICE | 2019年 / 25卷 / 09期
关键词：
NEUROTROPHIC FACTOR; MORTALITY; MELLITUS; RISK;
D O I：
10.4158/EP-2019-0266
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：968 / 970
页数：3
相关论文
共 50 条
  • [21] hs-CRP Predicts Improvement in Depression in Patients With Type 1 Diabetes and Major Depression Undergoing Depression Treatment: Results From the Diabetes and Depression (DAD) Study
    Zahn, Daniela
    Herpertz, Stephan
    Albus, Christian
    Hermanns, Norbert
    Hiemke, Christoph
    Hiller, Wolfgang
    Kronfeld, Kai
    Kruse, Johannes
    Kulzer, Bernd
    Mueller, Matthias J.
    Ruckes, Christian
    Petrak, Frank
    DIABETES CARE, 2016, 39 (10) : E171 - E173
  • [22] Antidepressant treatment and mortality in people with comorbid depression and type 2 diabetes: UK electronic health record study
    Jeffery, Annie
    Walters, Kate
    Wong, Ian
    Osborn, David
    Hayes, Joseph
    BJPSYCH OPEN, 2024, 10 (03):
  • [23] Impact of comorbid depression on glycemic control and family functioning in treatment-resistant type 2 diabetes patients
    Saeki, T.
    Takaishi, M.
    Yamawaki, S.
    Ishida, K.
    Komo, T.
    Tazuma, S.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 : 96 - 96
  • [24] Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression
    Bhattacharya, Rituparna
    Shen, Chan
    Wachholtz, Amy B.
    Dwibedi, Nilanjana
    Sambamoorthi, Usha
    BMC PSYCHIATRY, 2016, 16
  • [25] Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression
    Rituparna Bhattacharya
    Chan Shen
    Amy B. Wachholtz
    Nilanjana Dwibedi
    Usha Sambamoorthi
    BMC Psychiatry, 16
  • [26] Comorbidity of depression and type 2 diabetes in Egypt results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study
    Okasha, Tarek
    Mostafa, Bassem Murad
    Ibrahim, Islam
    Abdelgawad, Ahmed Adel
    Lloyd, Cathy E.
    Sartorius, Norman
    Elkholy, Hussien
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2024, 70 (04) : 730 - 738
  • [27] Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression Results From the AGOPSYCH Study
    Englisch, Susanne
    Jung, Hanna Sophie
    Eisenacher, Sarah
    Lewien, Antje
    Becker, Anna
    Nowak, Ulrike
    Braun, Hanna
    Thiem, Jascha
    Meyer-Lindenberg, Andreas
    Zink, Mathias
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 357 - 361
  • [28] Comorbid depression and anxiety: Integration of insights from attachment theory and cognitive neuroscience, and their implications for research and treatment
    Rajkumar, Ravi Philip
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [29] A collaborative care approach delivering treatment to patients with depression comorbid with diabetes or cardiovascular disease achieves significant but small improvements over usual care in depression and patient satisfaction
    Sharpe, Michael
    EVIDENCE-BASED MENTAL HEALTH, 2015, 18 (04) : 122 - 122
  • [30] A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression
    Vanelle, J. -M.
    Douki, S.
    EUROPEAN PSYCHIATRY, 2006, 21 (08) : 523 - 530
12345